Lonza · 1 day ago
Director, Global DFS Direct Procurement
Lonza is a global leader in life sciences manufacturing, and they are seeking a Director of Global Direct Procurement for Dosage Form Solutions (DFS) to lead their sourcing strategies worldwide. This role focuses on driving innovation, strengthening supplier partnerships, and delivering sustainable value that impacts millions of lives.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Lead global procurement strategies for DFS Direct Materials to deliver cost, quality, and service improvements
Build and maintain strong supplier relationships to drive innovation and ensure continuity of supply
Develop and execute category strategies aligned with business objectives
Manage risk and supply assurance through proactive planning and mitigation strategies
Represent Procurement in key customer engagements and cross-functional initiatives
Lead and develop a global team of category managers and strategic buyers
Champion continuous improvement and digital procurement capabilities
Qualification
Required
Master's degree in business Admin, Procurement, Health & Nutrition or Pharma required
10+ years of Pharma and Health & Nutrition global procurement experience in a matrixed environment required
Strong leadership and influencing skills with experience managing teams
Expertise in category management, supplier management, negotiations, and contracting
Experience with e-procurement systems and global supplier programs
Strategic thinker with strong analytical and problem-solving skills
Preferred
Background in life sciences, CDMO, or related industries
Benefits
An agile career and dynamic working culture.
An inclusive and ethical workplace.
Compensation programs that recognize high performance.
A variety of benefits dependent on role and location.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
2026-01-07
2026-01-05
Company data provided by crunchbase